Skip to main content
. Author manuscript; available in PMC: 2012 Jan 23.
Published in final edited form as: J Parkinsons Dis. 2011 Nov;1(4):299–320.

Figure 1.

Figure 1

Synopsis. The role of molecular chaperones in Parkinson’s disease can be summarized by two leading hypotheses: I) Molecular chaperones protect neurons against α-synuclein induced toxicity and II) Depletion of molecular chaperones exacerbates protein toxicity and neurodegeneration. Molecular chaperones are neuroprotective because of a myriad of actions that mitigate protein misfolding and aggregation. UPS (ubiquitin-proteasome system); ALP (autophagy-lysosomal pathway)